ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,209.16
-0.65%
Dow Jones
38,571.03
-0.30%
Gold vs US Dollar
2,330.44
-0.87%
Brent Oil
76.765
-1.76%
Bitcoin
68,796.50
-0.01%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX

  6. Navidea Biopharmaceuticals Inc (NAVB) Share Price

NAVB Navidea Biopharmaceuticals Inc

0.0779
0.00 (0.00%)
Pre Market
Last Updated: 01:00:00
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Navidea Biopharmaceuticals Inc AMEX:NAVB American Stock Exchange Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.00 0.00 0.0779 0.00 0.00 0.00 0.00   00:00:00   
*quotes are delayed by at least 20 minutes
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 In Vitro,in Vivo Diagnostics 66k -17.22M -0.1724 -0.46 7.99M
 Type  Size  Price  Time  Units 
   0.00  
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore NAVB News
21/12/202320:32EDGAR2Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
05/12/202323:26EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
01/12/202316:49EDGAR2Form 8-K - Current report
16/11/202321:55EDGAR2Form 8-K - Current report
23/10/202318:56EDGAR2Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
06/10/202302:01BWNavidea Biopharmaceuticals, Inc. Announces NYSE American’s Decision to Suspend Trading In Its Common Stock
05/10/202321:21EDGAR2Form DEF 14A - Other definitive proxy statements
Period
Draw mode
Data Downloads for NAVB

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Navidea Biopharmaceuticals Inc Articles